Evidence map›Paper›PMID 41084769›Full record

ArticlePharmacogenomics

Characterizing models for delivery of pharmacogenomic testing: a scoping review.

Zeina Waheed, Mary Bunka, Louisa Edwards, Chad Bousman, Alison Hoens, Jehannine J Austin, Stirling Bryan

Abstract readScoping Review
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmacogenomics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zeina WaheedSchool of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Mary BunkaSchool of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Louisa EdwardsSchool of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Chad BousmanDepartment of Medical Genetics, University of Calgary, Calgary, BC, Canada.
Alison HoensDepartment of Physical Therapy, University of British Columbia, Vancouver, BC, Canada.
Jehannine J AustinDepartment of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
Stirling BryanSchool of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pharmacogenomic (PGx) testing can help guide medication prescribing for a wide range of health indications. The objective of this scoping review was to understand how PGx testing has been clinically implemented and learn from these experiences. Research questions guiding this work were: (1) what different models for delivery of PGx testing have been employed? (2) what are the characteristics of each delivery model? and (3) what are the reported facilitators and barriers associated with each delivery model? A total of 134 articles reported on 125 PGx initiatives spanning 19 countries. Four unique delivery models were identified: sole prescriber-led (

Indexed as

PharmacogeneticsPharmacogenomic TestingDelivery of Health CareHumansPharmacistshealthcare delivery modelsimplementationpharmacogeneticspharmacogenomicsprecision medicineprescribing optimizationscoping review

Identifiers

PMID41084769
PMCPMC12667736

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.